A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Chronic Peripheral Neuropathy Pain in Diabetics Clinical Trial

Official title: An Open-Label 52-Week Safety Study of Bicifadine SR in Adult Outpatients With Chronic Peripheral Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Status Terminated

Clinical Trial Summary

This study is to evaluate the long-term efficacy and safety of two dosages of bicifadine SR (600 mg/day and 1200 mg/day) for up to 52 weeks in reducing chronic peripheral neuropathy pain due to diabetes in adult outpatients.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Chronic Peripheral Neuropathy Pain in Diabetics
• Diabetic Neuropathies
• Neuralgia
• Peripheral Nervous System Diseases

• NCT number: NCT00597649
• Study type: Interventional
• Source: XTL Biopharmaceuticals
• Status: Terminated
• Phase: Phase 2
• Start date: October 2007
• Completion date: December 2008